Role of bone-forming agents in the management of osteoporosis

被引：28
|
作者：
McClung, Michael R. [1 ,2 ]
机构：
[1] Oregon Osteoporosis Ctr, Portland, OR 97225 USA
[2] Australian Catholic Univ, Mary MacKillop Ctr Hlth Res, Melbourne, Vic, Australia
来源：
AGING CLINICAL AND EXPERIMENTAL RESEARCH | 2021年 / 33卷 / 04期
基金：
美国国家卫生研究院;
关键词：
Osteoporosis; Osteoanabolic; Abaloparatide; Romosozumab; Teriparatide; Sequence;
D O I：
10.1007/s40520-020-01708-8
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
Recent evidence confirms the superiority of osteoanabolic therapy compared to anti-remodeling drugs for rapid improvement in bone density and fracture risk reduction, providing strong justification for the use of these anabolic agents as the initial therapy in high-risk patients, to be followed by anti-remodeling therapy. This review will highlight the results of recent studies and define the current status of osteoanabolic therapy for osteoporosis.
引用
收藏
页码：775 / 791
页数：17
相关论文
共 50 条
  • [31] A WNT protein therapeutic improves the bone-forming capacity of autografts from aged animals
    Chen, Tao
    Li, Jingtao
    Cordova, Luis A.
    Liu, Bo
    Mouraret, Sylvain
    Sun, Qiang
    Salmon, Benjamin
    Helms, Jill
    SCIENTIFIC REPORTS, 2018, 8
  • [32] Advances in Osteoporosis Therapy: Focus on Osteoanabolic Agents, Secondary Fracture Prevention, and Perioperative Bone Health
    Kostenuik, Paul J.
    Binkley, Neil
    Anderson, Paul A.
    CURRENT OSTEOPOROSIS REPORTS, 2023, 21 (04) : 386 - 400
  • [33] Emerging anabolic agents in the treatment of osteoporosis
    Lovato, Christina
    Lewiecki, E. Michael
    EXPERT OPINION ON EMERGING DRUGS, 2017, 22 (03) : 247 - 257
  • [34] Osteoporosis Management in the Era of COVID-19
    Yu, Elaine W.
    Tsourdi, Elena
    Clarke, Bart L.
    Bauer, Douglas C.
    Drake, Matthew T.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 (06) : 1009 - 1013
  • [35] The role of bone turnover markers in monitoring treatment in postmenopausal osteoporosis
    Szulc, Pawel
    CLINICAL BIOCHEMISTRY, 2012, 45 (12) : 907 - 919
  • [36] Novel bone-targeted agents for treatment of osteoporosis
    Wang, JB
    Yang, CH
    Yan, XM
    Wu, XH
    Xie, YY
    CHINESE CHEMICAL LETTERS, 2005, 16 (07) : 859 - 862
  • [37] The role of polyphenols on bone metabolism in osteoporosis
    Dudaric, Luka
    Fuzinac-Smojver, Ariana
    Muhvic, Damir
    Giacometti, Jasminka
    FOOD RESEARCH INTERNATIONAL, 2015, 77 : 290 - 298
  • [38] Anabolic Agents: A New Chapter in the Management of Osteoporosis
    Khan, Abdul-Wahab
    Khan, Aliya
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2006, 28 (02) : 136 - 141
  • [39] Exploring molecular mechanism of bone-forming capacity of Eurycoma longifolia: Evidence of enhanced expression of bone-related biomarkers
    Thu, Hnin Ei
    Mohamed, Isa Naina
    Hussain, Zahid
    Shuid, Ahmad Nazrun
    JOURNAL OF AYURVEDA AND INTEGRATIVE MEDICINE, 2018, 9 (04) : 272 - 280
  • [40] Novel Bone-targeted Agents for Treatment of Osteoporosis
    Jun Bo WANG
    ChineseChemicalLetters, 2005, (07) : 859 - 862
12345